SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCVS Group Regulatory News (CVSG)

Share Price Information for CVS Group (CVSG)

Share Price is delayed by 15 minutes
Get Live Data
1,231.00    7.00 (0.57%)
Bid:
1,229.00
Ask:
1,230.00
Spread: 1.00 (0.081%)
Market Cap: £858.56m
CVSG Live PriceLast checked at - London Stock Exchange

Intraday CVS Group Share Chart

Acquisitions/Trading Update

13 Dec 2007 07:01

CVS Group plc13 December 2007 For Immediate Release 13 December 2007 CVS Group plc ("CVS" or "the Group") Acquisitions and Pre-close Trading Update Acquisitions CVS, one of the UK's leading providers of veterinary services, is pleased toannounce three single site practice acquisitions located in Kidsgrove inStaffordshire, Fleet in Hampshire and Doncaster. The practices achieved aggregate EBITDA of £276,000 on turnover of £1.986m fortheir respective latest financial reporting periods. The consideration, which isnot being disclosed for reasons of commercial sensitivity, is being satisfiedwholly in cash. The acquired practices employ a total of 10 vets bringing the Group total toalmost 300. Commenting on the acquisitions, CVS Chief Executive Simon Innes said "Each ofthese three practices enjoys a strong reputation for clinical care and we lookforward to developing an excellent long term relationship with their respectiveteams". Pre-close Trading Update With five months of the current financial year now behind us the Board isdelighted to report continued strong progress on all fronts. We started the financial year with 43 small animal practices operating from 120surgeries and with one equine specialist practice and three veterinarydiagnostic laboratories. In the period up to flotation in early October weacquired a further two small animal practices operating from seven surgerieswhich, together with the significant number of acquisitions made in the secondhalf of last financial year, gave us a substantially higher EBITDA run-rate thanthe actual historic EBITDA of £5.1m achieved for the year ended 30 June 2007. Since flotation we have acquired a further four small animal practices,including the three announced today, operating from six surgeries and employing24 vets. Our pipeline of potential acquisitions remains strong, assisted by thedemographics which have now been prevalent in the sector for a few years. We will remain focused on acquiring well established practices achievingexcellence in terms of clinical care and where each practice employs at leastthree vets. The central services provided by the Group remain very attractive tovets, enabling individual surgeries to focus on clinical care. Our organic growth continues to be firm and we are confident of achievinganother year of significant progress in executing our strategy. Contacts:CVS Group plc 01379 644 288Simon Innes, Chief ExecutivePaul Coxon, Finance Director Buchanan CommunicationsRichard Oldworth 0207 466 5000Suzanne Brocks 07776 234 600 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
12th Jan 20241:56 pmRNSExercise of SAYE Options and PDMR Dealing
12th Jan 20247:00 amRNSBlock Listing Interim Review
5th Jan 20242:44 pmRNSReplacement of Director/PDMR Shareholding
5th Jan 202410:25 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Dec 20237:48 amRNSBlock Listing Application
30th Nov 20237:00 amRNSExercise of Options and Total Voting Rights
29th Nov 20233:43 pmRNSResult of AGM
29th Nov 20237:00 amRNSAGM Statement and Trading Update
24th Nov 20233:56 pmRNSGrant of Options under CVS Group plc
3rd Nov 20237:05 amRNSPosting of Annual Report and Notice of AGM
31st Oct 20234:46 pmRNSExercise of Options and Total Voting Rights
27th Oct 20237:00 amRNSDirectorate Change
13th Oct 20235:21 pmRNSConfirmation of dividend dates
9th Oct 20232:58 pmRNSExercise of Options, PDMR Dealing, EBT and TVR
29th Sep 20237:00 amRNSExercise of Options and Total Voting Rights
21st Sep 20237:00 amRNSFinal results for the year ended 30 June 2023
7th Sep 202310:50 amRNSResponse to CMA review into veterinary market
31st Aug 20237:00 amRNSExercise of Options and Total Voting Rights
31st Jul 20237:00 amRNSTotal Voting Rights
27th Jul 20237:00 amRNSTrading update, AU expansion and UK acquisitions
12th Jul 20237:00 amRNSBlock Listing Interim Review and TVR Update
30th Jun 20237:00 amRNSExercise of Options and Total Voting Rights
22nd Jun 20237:00 amRNSDirectorate Change
31st May 20237:00 amRNSExercise of Options and Total Voting Rights
12th May 20234:41 pmRNSStandard form for notification of major holdings
5th May 20238:53 amRNSBlock Listing Application
2nd May 20237:00 amRNSTotal Voting Rights
31st Mar 20231:39 pmRNSHolding(s) in Company
31st Mar 20237:00 amRNSTotal Voting Rights
10th Mar 202310:37 amRNSExercise of SAYE Options, PDMR Dealing and TVR
28th Feb 20237:00 amRNSExercise of Options and Total Voting Rights
24th Feb 20237:00 amRNSInterim Results
2nd Feb 20234:42 pmRNSExercise of Options and Total Voting Rights
26th Jan 20237:00 amRNSHalf year Trading Update
11th Jan 20234:31 pmRNSBlock Listing Interim Review and TVR Update
10th Jan 202312:24 pmRNSExercise of SAYE Options and PDMR Dealing
30th Dec 20227:00 amRNSExercise of Options and Total Voting Rights
20th Dec 20224:38 pmRNSExercise of Options and PDMR Dealing
30th Nov 20227:00 amRNSExercise of Options and Total Voting Rights
25th Nov 20224:22 pmRNSSAYE Option Scheme & PDMR Dealing
23rd Nov 20222:31 pmRNSResult of AGM
23rd Nov 20227:00 amRNSAGM Statement and Trading Update
8th Nov 20227:00 amRNSCapital Markets Day
31st Oct 20227:00 amRNSExercise of Options and Total Voting Rights
28th Oct 202210:22 amRNSAnnual Report, Notice of AGM & Dividend Timetable
12th Oct 202210:52 amRNSHolding(s) in Company
7th Oct 20227:00 amRNSDirector/PDMR Shareholding
30th Sep 20224:19 pmRNSLong Term Incentive Plan Awards and PDMR Dealing
30th Sep 20227:00 amRNSExercise of Options and Total Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.